JPM
JPMorgan Chase & Co.
JPM has lower modeled downside risk, despite its lower overall score.
PRAA
PRA Group, Inc.
PRAA has the edge over JPM overall, supported by stronger valuation and stronger fundamentals.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
PRAA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
PRAA's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like PRAA.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
PRAA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 2.9x | $11.88 | — |
| Forward | 6.5x | $11.88 | — |
| Cheap | 9.6x | $39.16 | +230% |
| Fair | 11x | $47.03 | +296% |
| Expensive | 20x | $83.73 | +605% |
Historical ranges are pointers, not guarantees.
PRAA has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
JPM has the edge over PRAA on the outlook, with more favorable valuation and earnings expectations.
PRAA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Stable | |
| Stable | |
| Limited | |
| High |
Analysts expect PRAA's earnings, revenue and profitability to hold roughly steady.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over PRAA on earnings, with more consistent year-over-year improvement.
PRAA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.82 | -55% |
| Q3 2026 | $4.10 | +$12.89 |
| Q2 2026 | -$6.72 | -388% |
| Q1 2026 | -$7.15 | -499% |
| Q4 2025 | -$7.79 | -535% |
| Q3 2025 | -$8.79 | -899% |
| Q2 2025 | $2.33 | +2230% |
| Q1 2025 | $1.79 | +$2.33 |
| Q4 2024 | $1.79 | +$3.92 |
PRAA has returned to profit: it earned $4.10 per share over the past year, after losing money the year before.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over PRAA on profitability, with a higher operating margin.
PRAA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $286.3M | -8% |
| Q2 2026 | $372.2M | +29% |
| Q1 2026 | $314.5M | +17% |
| Q4 2025 | $333.4M | +14% |
| Q3 2025 | $311.1M | +11% |
| Q2 2025 | $287.7M | +1.2% |
| Q1 2025 | $269.6M | +5.5% |
| Q4 2024 | $293.2M | +32% |
PRAA has the edge over JPM on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | +131 points |
| Q2 2026 | 41% | +12 points |
| Q1 2026 | 33% | +5.2 points |
| Q4 2025 | 38% | +5.6 points |
| Q3 2025 | -101% | -133 points |
| Q2 2025 | 30% | -1.8 points |
| Q1 2025 | 28% | +1.7 points |
| Q4 2024 | 32% | +12 points |
PRAA's operating margin was 30% last quarter, up 131 points from the same quarter a year ago.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
PRAA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$22.7M | -$11.3M |
| Q2 2026 | -$38.7M | -$24.5M |
| Q1 2026 | $23.5M | +$77M |
| Q4 2025 | -$11.3M | -127% |
| Q3 2025 | -$11.3M | +$24.7M |
| Q2 2025 | -$14.2M | +$16.6M |
| Q1 2025 | -$53.5M | +$20M |
| Q4 2024 | $41.8M | +107% |
PRAA has the edge over JPM on cash flow, with more consistent year-over-year improvement.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over PRAA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
PRAA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.7% | -282K shares |
| 1 year | -2.7% | -1.1M shares |
| 3 years | -3.1% | -1.2M shares |
| 5 years | -17% | -7.6M shares |
| Available history | -17% | -7.6M shares |
PRAA has 38M diluted shares, down 2.7% from a year ago, with $30M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $10M |
| Q1 2026 | $10M |
| Q4 2025 | $10M |
| Q3 2025 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q1 2023 | — |
PRAA spent $30M buying back its own shares over the past year.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
PRAA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.4x | Net Cash |
| Q4 2024 | -0.3x | Net Cash |
| Q3 2024 | -0.5x | Net Cash |
| Q2 2024 | -0.5x | Net Cash |
| Q1 2024 | -0.5x | Net Cash |
| Q4 2023 | -1.0x | Net Cash |
| Q3 2023 | -0.8x | Net Cash |
PRAA has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like PRAA.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
PRAA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 21.1 | Neutral |
PRAA's weekly RSI is 33 (neutral) and its Stochastic is 21 (neutral).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
PRAA PE vs Financial Services Sector
| Metric | PRAA | Sector median | Relative |
|---|---|---|---|
| PE | 2.9x | 13x | 78% below |
| PE % | 0 | 63 | 63 pts below |
PRAA has the edge over JPM on valuation relative to its sector.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over PRAA on trend strength, trading above more of its moving averages.
PRAA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $17.8 | 33% below |
| 20 week MA | $18.5 | 36% below |
| 50 week MA | $17.4 | 32% below |
| 100 week MA | $17.4 | 32% below |
| 200 week MA | $21.0 | 43% below |
PRAA is in a downtrend: it's below all five of its weekly moving averages, and 43% below its 200-week average.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over PRAA on returns for 2026, with the stronger performance.
PRAA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $36.5 | $38.8 | +6.2% |
| 2021 | $38.8 | $48.5 | +25% |
| 2022 | $48.5 | $33.4 | -31% |
| 2023 | $33.4 | $26.2 | -22% |
| 2024 | $26.2 | $20.5 | -22% |
| 2025 | $20.5 | $17.6 | -14% |
| 2026 YTD | $17.6 | $11.9 | -33% |
PRAA has finished four years in a row lower, and it's down 33% so far in 2026.